PortfoliosLab logoPortfoliosLab logo
JSPR vs. NGS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JSPR vs. NGS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jasper Therapeutics, Inc. (JSPR) and Natural Gas Services Group, Inc. (NGS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JSPR achieves a -73.70% return, which is significantly lower than NGS's 23.70% return.


JSPR

1D
-9.58%
1M
-50.19%
YTD
-73.70%
6M
-74.12%
1Y
-91.98%
3Y*
-68.77%
5Y*
10Y*

NGS

1D
2.07%
1M
1.08%
YTD
23.70%
6M
28.91%
1Y
71.15%
3Y*
58.88%
5Y*
30.58%
10Y*
6.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JSPR vs. NGS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
JSPR
Jasper Therapeutics, Inc.
-73.70%-91.44%170.98%63.39%-93.85%-48.08%
NGS
Natural Gas Services Group, Inc.
23.70%26.53%66.67%40.31%9.46%12.22%

Correlation

The correlation between JSPR and NGS is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Sep 27, 2021

0.05

Fundamentals

Market Cap

JSPR:

$13.80M

NGS:

$527.17M

EPS

JSPR:

-$2.87

NGS:

$1.72

PB Ratio

JSPR:

4.06

NGS:

1.88

Total Revenue (TTM)

JSPR:

$0.00

NGS:

$179.40M

Gross Profit (TTM)

JSPR:

-$290.00K

NGS:

$87.76M

EBITDA (TTM)

JSPR:

-$72.26M

NGS:

$69.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JSPR vs. NGS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JSPR
JSPR Risk / Return Rank: 55
Overall Rank
JSPR Sharpe Ratio Rank: 77
Sharpe Ratio Rank
JSPR Sortino Ratio Rank: 22
Sortino Ratio Rank
JSPR Omega Ratio Rank: 22
Omega Ratio Rank
JSPR Calmar Ratio Rank: 22
Calmar Ratio Rank
JSPR Martin Ratio Rank: 1111
Martin Ratio Rank

NGS
NGS Risk / Return Rank: 8888
Overall Rank
NGS Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
NGS Sortino Ratio Rank: 8484
Sortino Ratio Rank
NGS Omega Ratio Rank: 8585
Omega Ratio Rank
NGS Calmar Ratio Rank: 9191
Calmar Ratio Rank
NGS Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JSPR vs. NGS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and Natural Gas Services Group, Inc. (NGS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JSPRNGSDifference
Sharpe ratioReturn per unit of total volatility

-3.07

Sortino ratioReturn per unit of downside risk

-4.76

Omega ratioGain probability vs. loss probability

0.70

1.35

-0.65

Calmar ratioReturn relative to maximum drawdown

-0.99

4.77

-5.76

Martin ratioReturn relative to average drawdown

-1.30

14.09

-15.39

JSPR vs. NGS - Sharpe Ratio Comparison

The current JSPR Sharpe Ratio is -0.88, which is lower than the NGS Sharpe Ratio of 2.19. The chart below compares the historical Sharpe Ratios of JSPR and NGS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


JSPRNGSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.88

2.19

-3.07

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.70

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.29

0.20

-0.49

Drawdowns

JSPR vs. NGS - Drawdown Comparison

The maximum JSPR drawdown since its inception was -99.71%, which is greater than NGS's maximum drawdown of -89.59%. Use the drawdown chart below to compare losses from any high point for JSPR and NGS.


Loading charts...

Drawdown Indicators


JSPRNGSDifference

Max Drawdown

Largest peak-to-trough decline

-99.71%

-89.59%

-10.12%

Max Drawdown (1Y)

Largest decline over 1 year

-92.94%

-15.00%

-77.94%

Max Drawdown (3Y)

Largest decline over 3 years

-98.40%

-40.89%

-57.51%

Max Drawdown (5Y)

Largest decline over 5 years

-40.89%

Max Drawdown (10Y)

Largest decline over 10 years

-87.91%

Current Drawdown

Current decline from peak

-99.71%

-5.09%

-94.62%

Average Drawdown

Average peak-to-trough decline

-88.46%

-47.48%

-40.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

70.70%

5.06%

+65.64%

Volatility

JSPR vs. NGS - Volatility Comparison

Jasper Therapeutics, Inc. (JSPR) has a higher volatility of 47.65% compared to Natural Gas Services Group, Inc. (NGS) at 12.03%. This indicates that JSPR's price experiences larger fluctuations and is considered to be riskier than NGS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JSPRNGSDifference

Volatility (1M)

Calculated over the trailing 1-month period

47.65%

12.03%

+35.62%

Volatility (6M)

Calculated over the trailing 6-month period

77.38%

22.17%

+55.21%

Volatility (1Y)

Calculated over the trailing 1-year period

105.09%

32.68%

+72.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

242.64%

44.04%

+198.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

242.64%

46.24%

+196.40%

Dividends

JSPR vs. NGS - Dividend Comparison

JSPR has not paid dividends to shareholders, while NGS's dividend yield for the trailing twelve months is around 1.14%.


PositionTTM2025
JSPR
Jasper Therapeutics, Inc.
0.00%0.00%
NGS
Natural Gas Services Group, Inc.
1.14%0.62%

Financials

JSPR vs. NGS - Financials Comparison

This section allows you to compare key financial metrics between Jasper Therapeutics, Inc. and Natural Gas Services Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M202220232024202520260
48.47M
(JSPR) Total Revenue
(NGS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


JSPR and NGS have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

JSPR has higher volatility (47.65%) compared to NGS (12.03%). In terms of maximum drawdown, JSPR dropped -99.71% vs NGS's -89.59%.

NGS currently has the higher Sharpe Ratio (2.19 vs -0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JSPR and NGS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer